However, the potential interactions of HOGA1 with other key pathways in ccRCC, such as MAPK, P53 and PI3K/AKT—pathways known to be critical in tumorigenesis—remain to be explored [46, 47, 48]. This evidence concerns the gene TP53 and nonpapillary renal cell carcinoma.